-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Protagenic Therapeutics, Inc.\new quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q1 2017 to Q1 2024.
- Protagenic Therapeutics, Inc.\new Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2024 was -$1.66M, a 346% decline year-over-year.
- Protagenic Therapeutics, Inc.\new annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$3.7M, a 85.8% decline from 2022.
- Protagenic Therapeutics, Inc.\new annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$1.99M, a 28.8% increase from 2021.
- Protagenic Therapeutics, Inc.\new annual Net Cash Provided by (Used in) Operating Activities for 2021 was -$2.8M, a 107% decline from 2020.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)